Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cubist antibiotic succeeds in late-stage trial, shares rise
Cubist antibiotic succeeds in late-stage trial, shares rise
Cubist antibiotic succeeds in late-stage trial, shares rise
Submitted by
admin
on December 16, 2013 - 9:02am
Source:
Reuters
News Tags:
ceftolozane/tazobactam
Cubist
antibiotics
intra-abdominal infections
Headline:
Cubist antibiotic succeeds in late-stage trial, shares rise
Do Not Allow Advertisers to Use My Personal information
